FT001, FT-001, FT 001, Epigenetic Reader Domain, EpigeneticReaderDomain, BET bromodomain
FT001 is a potent, selective, and orally bioavailable BET bromodomain inhibitor with antitumor activity. It suppresses MYC expression (IC50 = 0.46 µM) and demonstrates potent antiproliferative effects against MV-4-11 cells, along with significant MYC mRNA suppression in both in vitro and in vivo models.
Molecular Weight:
467.58
Purity:
>99.99% (May vary between batches)
CAS Number:
[1778655-51-8]
Formula:
C25H29N3O4S
Target:
Epigenetic Reader Domain
Application Notes:
Solubility: DMSO:45 mg/mL (96.24 mM)
* VAT and and shipping costs not included. Errors and price changes excepted